Compagnie Chargeurs Invest (CRI) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
11 Sep, 2026Executive summary
H1 2025 revenue was stable at €372.2m (-0.6% reported), with strong growth in Museum Studio (+17.9% to +21%) and Personal Goods (+21.1%), offset by declines in Chargeurs PCC and Luxury Fibers.
Net Asset Value (NAV) rose to €24.2 per share as of June 30, 2025, up from €24.1 at year-end 2024, despite negative currency impacts.
The group is reviewing several expressions of interest for a potential disposal of Novacel, which could significantly enhance equity and investment capacity if executed.
Continued portfolio expansion in Culture & Education, including exclusive talks to acquire Chaplin's World and a majority stake in Lord Cultural Resources.
Corporate identity changed to Compagnie Chargeurs Invest in April 2025, reflecting a dual industrial and financial vocation.
Financial highlights
Group revenue was €372.2m (-0.6% reported, -1.7% like-for-like year-over-year).
Gross margin increased to €99.9m (26.8% of revenue), up 0.6% year-over-year.
EBITDA was €29.0m, down 2% year-over-year.
Operating profit rose 5.9% to €10.8m, while recurring operating profit declined 11.2% to €15.1m, mainly due to Chargeurs PCC.
Attributable net profit was -€8.3m, impacted by higher tax charges and non-recurring items.
Outlook and guidance
Targeting 8–10% average annual growth in NAV through 2030, with a normalized net debt/EBITDA ratio of 2x–3x.
Order intake at Novacel has increased since May, supporting confidence for year-end activity.
Proceeds from a potential Novacel disposal would support long-term expansion in Culture & Education and Fashion & Know-how platforms.
The group expects continued benefit from lower financial expenses in H2 2025, supported by lower interest rates and reduced leverage.
Latest events from Compagnie Chargeurs Invest
- Transformation to high-luxury focus, Novacel sale, and €14/share buyback drive strong outlook.CRI
Q2 2026 - Q1 2026 revenue fell, but strategic transformation accelerates with Novacel divestment and strong order books.CRI
Q1 2026 - Novacel sale and strategic refocus boost financial flexibility and target €1bn NAV by 2030.CRI
Q4 2025 - Strong Q3 growth in new businesses and luxury brands, with a robust outlook for 2026.CRI
Q3 2025 - Q3 2024 revenue up 11.2% year-over-year, led by Novacel and Museum Studio growth.CRI
Q3 2024 - Revenue up 11.1% and recurring operating profit up 33.9%, with strong cash flow and reduced net debt.CRI
Q2 2024 - Q1 2024 revenue up 10% as Chargeurs accelerates growth in high-value, sustainable markets.CRI
Investor Presentation - Strong growth, strategic transformation, and all resolutions passed amid market and regulatory risks.CRI
AGM 2025 - Museum Studio and Personal Goods drove 5.6% revenue growth in Q1 2025 amid global challenges.CRI
Q1 2025